Samsung Electronics Poised for Massive Q4 Profit Surge on Soaring Memory Chip Prices 
Intel Unveils Panther Lake AI Laptop Chips at CES 2025, Marking Major 18A Manufacturing Milestone 
Nvidia Unveils Rubin Platform to Power Next Wave of AI Infrastructure 
Tesla UK Sales Slide as Competition Intensifies, While BYD Surges in Electric Vehicle Market 
TSMC Shares Hit Record High as Goldman Sachs Raises Price Target on AI Demand Outlook 
SMIC Shares Climb as China Boosts Chipmaking Support Amid AI Optimism 
SGH’s A$13.15 Billion BlueScope Bid Sparks Steel Sector Shake-Up and Share Price Surge 
Hyundai Motor Shares Surge on Nvidia Partnership Speculation 
Mercedes-Benz to Launch Advanced Urban Self-Driving System in the U.S., Challenging Tesla FSD 
Samsung to Double AI-Powered Mobile Devices with Google Gemini in Global AI Race 
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 
Kia Targets 3.35 Million Global Vehicle Sales in 2026 Amid Steady Growth Outlook 
AMD Unveils Next-Generation AI and PC Chips at CES, Highlights Major OpenAI Partnership 
Tokyo Electric Power Shares Surge as Kashiwazaki-Kariwa Nuclear Reactor Restart Nears 
Barclays Invests in Stablecoin Clearing Firm Ubyx to Advance Digital Money Strategy 
Embraer Boosts Aircraft Deliveries in Q4 2025, Signaling Strong Growth Into 2026 
Baidu’s AI Chip Unit Kunlunxin Prepares for Hong Kong IPO to Raise Up to $2 Billion 
Dublin, Oct. 24, 2017 -- The "Global Regenerative Medicines Market" report has been added to Research and Markets' offering.
Regenerative medicine is a branch of medicine involved with the repair or replacement of damaged tissues or organs. The field uses various strategies like the cell therapy, gene therapy and tissue engineering among others to replace the missing or damaged tissue or organ.
These also include the implantable medical devices. Regenerative medicine offers a treatment option for the incurable diseases such as cardiac diseases, immune-oncology and orphan diseases among others.
The gene therapy involves modulation of the target gene. It involves either the replacement, modification, silencing or introduction of the desired gene into the patient's body. Gene therapy may be done in vivo, where the gene is transferred to cells inside the body.
It may also be done ex vivo where the gene is incorporated into the cells outside the body which are then transferred into the patient's body. Cell therapy involves the administration of living non genetically modified cells into the patient's body. These cells multiply to replace or repair the damaged organ or tissue.
The cells used could be allogenic or autogenic. Tissue engineering technique involves biomaterials, biologically active molecules, cells, tissues or scaffolds.
Key Topics Covered:
Executive Summary
1 Report Scope
2 Market Overview
3 Market Dynamics
4 Competitive Insights
5 Industry Insights
- Regulatory Scenario
- Patent Landscape
6 Global Regenerative Medicine Market, By Therapy
- Cell Therapy
- Gene Therapy
- Tissue Engineering
7 Global Regenerative Medicine Market, by Product
8 Global Regenerative Medicine Market, By Application
- Orthopaedic
- Cardiology
- Wound Healing
- Diabetes
- Immuno-Oncology
- Others
9 Global Regenerative Medicine Market, By Geography
10 Company Profiles
- Acelity
- Athersys
- Cellular Biomedicine Group
- Cytori Therapeutics Inc.
- Integra LifeSciences
- Mesoblast
- MiMedx
- Novartis AG
- Nuvasive
- Organogenesis
- Osiris Therapeutics
- Stryker
- Terumo Corporation
- TiGenix
- Tissue Regenix
- Vericel Corporation
- Viacyte
- Zimmer Biomet
For more information about this report visit https://www.researchandmarkets.com/research/wsw6m5/global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biopharmaceuticals
